David Meriwether
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 3
- Clinical Biochemistry top 5%
- Paraoxonase enzyme and polymorphisms 8
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
- Biochemistry top 10%
- Surgery top 10%
- Cholesterol and Lipid Metabolism 7
- Lipoproteins and Cardiovascular Health 2
-
- Inflammatory mediators and NSAID effects 4
-
- Sphingolipid Metabolism and Signaling 3
-
- Adipokines, Inflammation, and Metabolic Diseases 2
- Co-authors
- Srinivasa T. ReddyAlan M. FogelmanMohamad NavabVíctor GrijalvaFeng SuRobin Farias‐EisnerA. ChattopadhyayChristina Charles‐Schoeman
- Partner nations
- United StatesItalyAustralia
In The Last Decade
David Meriwether
33 papers receiving 895 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 235
- Clinical Biochemistry 79
- Endocrinology, Diabetes and Metabolism 177
- Biochemistry 55
- Surgery 331
Countries citing papers authored by David Meriwether
This map shows the geographic impact of David Meriwether's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Meriwether with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Meriwether more than expected).
Fields of papers citing papers by David Meriwether
This network shows the impact of papers produced by David Meriwether. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Meriwether. The network helps show where David Meriwether may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Meriwether, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2021 | 25 | |
| 6 | 2019 | 68 | |
| 7 | 2018 | 14 | |
| 8 | 2017 | 35 | |
| 9 | 2017 | 12 | |
| 10 | 2016 | 20 | |
| 11 | 2015 | 41 | |
| 12 | 2014 | 38 | |
| 13 | 2013 | 73 | |
| 14 | 2013 | 58 | |
| 15 | 2012 | 22 | |
| 16 | 2012 | 28 | |
| 17 | 2011 | 57 | |
| 18 | 2011 | 62 | |
| 19 | 2011 | 13 | |
| 20 | 2011 | 68 |
About David Meriwether
David Meriwether is a scholar working on Clinical Biochemistry, Virology, Biochemistry, Pharmacology and Biochemistry, having authored 35 papers that have together received 905 indexed citations. Recurring topics across this work include Paraoxonase enzyme and polymorphisms (8 papers), Cholesterol and Lipid Metabolism (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Inflammatory mediators and NSAID effects (4 papers), Sphingolipid Metabolism and Signaling (3 papers), Cancer, Lipids, and Metabolism (3 papers), Lipoproteins and Cardiovascular Health (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). The work is most often cited by research in Cancer Research (235 citations), Clinical Biochemistry (79 citations), Endocrinology, Diabetes and Metabolism (177 citations), Biochemistry (55 citations) and Surgery (331 citations). David Meriwether has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Srinivasa T. Reddy, Alan M. Fogelman, Mohamad Navab, Víctor Grijalva, Feng Su, Robin Farias‐Eisner, A. Chattopadhyay, Christina Charles‐Schoeman, Ekambaram Ganapathy and Satoshi Imaizumi. Their work appears in journals such as Journal of Lipid Research, Circulation Research, Circulation, Nutrition Metabolism and Cardiovascular Diseases and Cellular and Molecular Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.